Search by Drug Name or NDC

    NDC 70934-0170-30 Hydrochlorothiazide 12.5 mg/1 Details

    Hydrochlorothiazide 12.5 mg/1

    Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The primary component is HYDROCHLOROTHIAZIDE.

    Product Information

    NDC 70934-0170
    Product ID 70934-170_d60a439a-b853-73af-e053-2995a90a207a
    Associated GPIs 37600040000303
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5
    Active Ingredient Units mg/1
    Substance Name HYDROCHLOROTHIAZIDE
    Labeler Name Denton Pharma, Inc. DBA Northwind Pharmaceuticals
    Pharmaceutical Class Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202556
    Listing Certified Through n/a

    Package

    NDC 70934-0170-30 (70934017030)

    NDC Package Code 70934-170-30
    Billing NDC 70934017030
    Package 30 TABLET in 1 BOTTLE, PLASTIC (70934-170-30)
    Marketing Start Date 2018-09-19
    NDC Exclude Flag N
    Pricing Information N/A